EMERYVILLE, Calif., April 30 /PRNewswire-FirstCall/ -- Bionovo, Inc. announced today that it will release financial results for the first quarter of fiscal year 2009 ended March 31, 2009 on Thursday, May 7, 2009. The Company will conduct a conference call and webcast to review the financial results on Thursday, May 7, 2009 at 4:30 p.m. ET.
Interested parties can access the call by dialing (877) 356-5706 or (706) 643-0580, or can listen via a live Internet webcast, which can be found at http://bionovo.com/investors/events. A replay of the call will be available via webcast at http://bionovo.com/investors/events for 30 days or by playback at (800) 642-1687 or (706) 645-9291, access code 94818134, through May 10, 2009.
About Bionovo, Inc.
Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women’s health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, “BNVI”. For more information about Bionovo and its programs, visit: http://www.bionovo.com.
CONTACT: Claire Fong or Tom Chesterman, both of Bionovo, Inc.,
+1-510-601-2000, investor@bionovo.com; or Joe Diaz, Robert Blum, or Joe
Dorame, +1-602-889-9700, BNVI@lythampartners.com, all of Lytham Partners,
LLC, For Bionovo, Inc.
Web site: http://www.bionovo.com/
